Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC26798260;8261;8262 chr2:178771292;178771291;178771290chr2:179636019;179636018;179636017
N2AB26798260;8261;8262 chr2:178771292;178771291;178771290chr2:179636019;179636018;179636017
N2A26798260;8261;8262 chr2:178771292;178771291;178771290chr2:179636019;179636018;179636017
N2B26338122;8123;8124 chr2:178771292;178771291;178771290chr2:179636019;179636018;179636017
Novex-126338122;8123;8124 chr2:178771292;178771291;178771290chr2:179636019;179636018;179636017
Novex-226338122;8123;8124 chr2:178771292;178771291;178771290chr2:179636019;179636018;179636017
Novex-326798260;8261;8262 chr2:178771292;178771291;178771290chr2:179636019;179636018;179636017

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCT
  • RefSeq wild type template codon: CGA
  • Domain: Ig-16
  • Domain position: 59
  • Structural Position: 141
  • Q(SASA): 0.3101
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/T rs762303238 -0.788 0.001 N 0.103 0.1 0.191931220699 gnomAD-2.1.1 7.96E-06 None None None None N None 0 0 None 0 0 None 0 None 9.24E-05 0 0
A/T rs762303238 -0.788 0.001 N 0.103 0.1 0.191931220699 gnomAD-4.0.0 6.36236E-06 None None None None N None 0 0 None 0 0 None 3.76378E-05 0 5.71314E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.4183 ambiguous 0.4343 ambiguous -1.026 Destabilizing 0.356 N 0.413 neutral None None None None N
A/D 0.1546 likely_benign 0.1632 benign -1.494 Destabilizing None N 0.231 neutral N 0.483920002 None None N
A/E 0.1292 likely_benign 0.1282 benign -1.594 Destabilizing 0.016 N 0.417 neutral None None None None N
A/F 0.2253 likely_benign 0.2417 benign -1.279 Destabilizing 0.214 N 0.495 neutral None None None None N
A/G 0.1176 likely_benign 0.117 benign -1.058 Destabilizing 0.024 N 0.296 neutral N 0.512649789 None None N
A/H 0.2721 likely_benign 0.2693 benign -1.009 Destabilizing 0.628 D 0.465 neutral None None None None N
A/I 0.1496 likely_benign 0.1711 benign -0.642 Destabilizing 0.001 N 0.154 neutral None None None None N
A/K 0.1978 likely_benign 0.19 benign -1.128 Destabilizing 0.072 N 0.434 neutral None None None None N
A/L 0.1151 likely_benign 0.12 benign -0.642 Destabilizing 0.007 N 0.33 neutral None None None None N
A/M 0.1681 likely_benign 0.1793 benign -0.452 Destabilizing 0.214 N 0.435 neutral None None None None N
A/N 0.1665 likely_benign 0.1745 benign -0.87 Destabilizing 0.072 N 0.459 neutral None None None None N
A/P 0.1038 likely_benign 0.1038 benign -0.691 Destabilizing None N 0.132 neutral N 0.46607014 None None N
A/Q 0.1892 likely_benign 0.1821 benign -1.196 Destabilizing 0.356 N 0.457 neutral None None None None N
A/R 0.1954 likely_benign 0.1815 benign -0.584 Destabilizing 0.356 N 0.458 neutral None None None None N
A/S 0.0854 likely_benign 0.0849 benign -1.121 Destabilizing 0.012 N 0.329 neutral N 0.427946755 None None N
A/T 0.0735 likely_benign 0.0758 benign -1.151 Destabilizing 0.001 N 0.103 neutral N 0.451106007 None None N
A/V 0.0927 likely_benign 0.0985 benign -0.691 Destabilizing None N 0.106 neutral N 0.453311486 None None N
A/W 0.5496 ambiguous 0.5588 ambiguous -1.457 Destabilizing 0.864 D 0.506 neutral None None None None N
A/Y 0.3206 likely_benign 0.3364 benign -1.113 Destabilizing 0.356 N 0.486 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.